Sanders Morris Harris’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,500
| Closed | -$895K | – | 166 |
|
|
2025
Q1 | $895K | Hold |
3,500
| – | – | 0.14% | 101 |
|
|
2024
Q4 | $824K | Hold |
3,500
| – | – | 0.12% | 118 |
|
|
2024
Q3 | $963K | Hold |
3,500
| – | – | 0.16% | 96 |
|
|
2024
Q2 | $851K | Hold |
3,500
| – | – | 0.14% | 102 |
|
|
2024
Q1 | $523K | Hold |
3,500
| – | – | 0.1% | 150 |
|
|
2023
Q4 | $684K | Hold |
3,500
| – | – | 0.34% | 84 |
|
|
2023
Q3 | $625K | Hold |
3,500
| – | – | 0.13% | 126 |
|
|
2023
Q2 | $664K | Buy |
+3,500
| New | +$664K | 0.15% | 110 |
|
|
2023
Q1 | – | Sell |
-3,500
| Closed | -$832K | – | 146 |
|
|
2022
Q4 | $832K | Hold |
3,500
| – | – | 0.31% | 69 |
|
|
2022
Q3 | $688K | Hold |
3,500
| – | – | 0.17% | 100 |
|
|
2022
Q2 | $519K | Hold |
3,500
| – | – | 0.11% | 139 |
|
|
2022
Q1 | $572K | Hold |
3,500
| – | – | 0.11% | 144 |
|
|
2021
Q4 | $596K | Hold |
3,500
| – | – | 0.1% | 152 |
|
|
2021
Q3 | $714K | Hold |
3,500
| – | – | 0.13% | 122 |
|
|
2021
Q2 | $610K | Hold |
3,500
| – | – | 0.12% | 141 |
|
|
2021
Q1 | $492K | Hold |
3,500
| – | – | 0.1% | 159 |
|
|
2020
Q4 | $598K | Hold |
3,500
| – | – | 0.14% | 133 |
|
|
2020
Q3 | $514K | Buy |
3,500
+700
| +25% | +$103K | 0.14% | 140 |
|
|
2020
Q2 | $417K | Buy |
+2,800
| New | +$417K | 0.2% | 63 |
|